DICE Therapeutics
Latest round
- Series C
Last raised
- Aug 2021
Total raised
- $155M
Investors
- 15
About DICE Therapeutics
Based in California, US, and founded in 2013 by founder and CEO Kevin Judice and Phil Patten, DICE Therapeutics, Inc. operates as a developer of a transformative platform to discover novel small molecules. DICE Therapeutics, Inc. operates as a biotechnology company that develops small molecule compounds for targeted oral medicines through protein-protein interaction (PPI) therapeutics to treat patients with serious medical conditions. The funds collected from the IPO in September 2021, will be used to promote the development of oral medicines that might compete with biological treatments.
Who invested in DICE Therapeutics
15 investors across 4 rounds
See all investors in DICE Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DICE Therapeutics
Who invested in DICE Therapeutics?
DICE Therapeutics has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DICE Therapeutics raised?
DICE Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did DICE Therapeutics last raise money?
DICE Therapeutics's most recent round on record is a Series C, in Aug 2021.
What does DICE Therapeutics do?
Based in California, US, and founded in 2013 by founder and CEO Kevin Judice and Phil Patten, DICE Therapeutics, Inc.
Where is DICE Therapeutics headquartered?
DICE Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like DICE Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at DICE Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like DICE Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.